March 10, 2026

Amneal Pharmaceuticals, Inc. (AMRX): Investor Outlook Highlights 26.79% Potential Upside

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), a prominent player in the healthcare sector focused on specialty and generic drug manufacturing, stands as an intriguing prospect for investors seeking potential growth within..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Navigating a 11.56% Potential Upside in the Biotech Arena

Investors with an appetite for potential growth in the biotech sector should consider Protagonist Therapeutics, Inc. (NASDAQ: PTGX). With a market capitalization of $6.17 billion, this Newark, California-based company is..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: A Look at Its 150% Potential Upside

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) stands as a beacon of innovation in the biotechnology industry, particularly in the niche of rare and ultra-rare genetic diseases. With a market cap of..

PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: Exploring a 28.66% Upside Potential in the Healthcare Robotics Sector

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is carving a niche for itself in the healthcare sector, particularly within the medical devices industry. This San Jose-based company is known for its innovative..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: Uncovering a 37.15% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is making waves in the biotechnology sector, offering investors a tantalizing opportunity with its potential upside of 37.15%. As a commercial-stage biopharmaceutical company, Catalyst focuses..

Warby Parker Inc. (WRBY) Stock Analysis: Eyeing a 13.40% Upside with Strong Buy Ratings

Warby Parker Inc. (WRBY), a notable player in the healthcare sector, is garnering attention with its promising investment outlook. Known for its innovative approach to selling eyewear products, this New..

Concentra Group Holdings Parent (CON): A Promising Investment with 28% Upside Potential

Concentra Group Holdings Parent, Inc. (NASDAQ: CON), a key player in the healthcare sector, is making waves among investors with its strong foothold in the medical care facilities industry. Headquartered..

Drax Foundation funding targets education, skills and environmental projects

Drax expands foundation funding to support education, environmental engagement and community programmes across the UK, the United States and Canada...

ImmunityBio, Inc. (IBRX) Stock Analysis: Eyeing an 80% Potential Upside in the Biotech Arena

In the ever-evolving landscape of biotechnology, ImmunityBio, Inc. (NASDAQ: IBRX) stands out with its ambitious innovations in immunotherapy. Based in San Diego, California, ImmunityBio is at the forefront of developing..

Metsera, Inc. (MTSR) Stock Analysis: A Clinical-Stage Biotech with a -19.15% Potential Downside

Metsera, Inc. (MTSR) is a clinical-stage biotechnology company making strides in the healthcare sector, especially in the fight against obesity and related metabolic disorders. Incorporated in 2022 and currently a..

Surgery Partners, Inc. (SGRY) Stock Analysis: Evaluating a 45% Upside Potential in the Healthcare Sector

Surgery Partners, Inc. (NASDAQ: SGRY) stands as a prominent player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Brentwood, Tennessee, the company boasts a comprehensive..

ICU Medical, Inc. (ICUI) Stock Analysis: Exploring a 36.99% Upside Potential

ICU Medical, Inc. (NASDAQ: ICUI), a key player in the healthcare sector, specializes in the development, manufacturing, and distribution of essential medical instruments and supplies. With a market cap of..

Zai Lab Limited (ZLAB): Analyst Consensus Suggests Over 100% Upside Potential

Zai Lab Limited (NASDAQ: ZLAB), a notable player in the biotechnology sector, is capturing attention with its promising growth potential and strategic collaborations. With a market capitalization of $2.12 billion,..

Arcellx, Inc. (ACLX) Stock Analysis: Strong Pipeline but Challenging Financials

Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company specializing in innovative immunotherapies, is currently navigating a complex financial landscape while advancing its promising clinical pipeline. With a market capitalization of $6.7..

Why predictive intelligence is changing the Medical Science Liaison model

Predictive analytics is enabling Medical Affairs teams to identify emerging clinical discussions earlier and engage the most relevant healthcare professionals...

Geopolitics and AI narratives reprice risk across global markets

Geopolitical tensions and speculation around artificial intelligence are reshaping market sentiment and highlighting the importance of diversification for investors...

Energy shock revives inflation and rate risks for global investors

Energy market disruption from geopolitical conflict is pushing oil prices higher and raising concerns about inflation, interest rates and economic growth...

Marshalls to host live Investor Presentation following 2026 final results

Marshalls plc will host a live interactive presentation for investors on 20 March 2026 via the Engage Investor platform, following the release of its Final Results on 16 March...

Domino’s Pizza Group delivers solid FY2025 finish, maintains outlook for 2026

Domino’s Pizza Group posted modest sales growth in FY2025 and strong cash generation, supporting a higher dividend. The company said trading in early 2026 remains in line with market expectations..

Grafton Group agrees deal to acquire Cygnum in Ireland

Grafton Group has agreed to acquire Irish offsite timber frame supplier Cygnum Holdings, strengthening Chadwicks Group’s offering and expanding its exposure to Ireland’s growing modular housing market...
Search

Funds

March 10, 2026

Drax Foundation funding targets education, skills and environmental projects

Drax expands foundation funding to support education, environmental engagement and community programmes across the UK, the United States and Canada...

Why predictive intelligence is changing the Medical Science Liaison model

Predictive analytics is enabling Medical Affairs teams to identify emerging clinical discussions earlier and engage the most relevant healthcare professionals...

Geopolitics and AI narratives reprice risk across global markets

Geopolitical tensions and speculation around artificial intelligence are reshaping market sentiment and highlighting the importance of diversification for investors...

Energy shock revives inflation and rate risks for global investors

Energy market disruption from geopolitical conflict is pushing oil prices higher and raising concerns about inflation, interest rates and economic growth...

Marshalls to host live Investor Presentation following 2026 final results

Marshalls plc will host a live interactive presentation for investors on 20 March 2026 via the Engage Investor platform, following the release of its Final Results on 16 March...

Domino’s Pizza Group delivers solid FY2025 finish, maintains outlook for 2026

Domino’s Pizza Group posted modest sales growth in FY2025 and strong cash generation, supporting a higher dividend. The company said trading in early 2026 remains in line with market expectations as it focuses on core growth, digital expansion, and operational efficiency...

Grafton Group agrees deal to acquire Cygnum in Ireland

Grafton Group has agreed to acquire Irish offsite timber frame supplier Cygnum Holdings, strengthening Chadwicks Group’s offering and expanding its exposure to Ireland’s growing modular housing market...
Search

Funds

March 10, 2026

FTSE 100

Funds